Company / Tangible Book Value per Share
ELITE PHARMACEUTICALS INC /NV/ Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$0.05
FY2025
5-year range
$0.02 / $0.06
FY2021-FY2025
Trend
-11.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Tangible Book Value per Share has fluctuated over the past 10 years, ranging from $-0.05 in FY2016 to $0.06 in FY2024.
Based on SEC 10-K filings.
0.05 in FY2025 with a 5-year CAGR of +31.1%.
Improved from $0.03 to $0.05 over the past 2 years.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- +26.1%
- 5-Year CAGR
- +31.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, tangible book value per share decreased 11.8% year-over-year.
- Peak tangible book value per share was recorded in FY2024.
- Lowest tangible book value per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.05 | -11.8% |
| FY2024 | $0.06 | +98.3% |
| FY2023 | $0.03 | +14.6% |
| FY2022 | $0.02 | +30.0% |
| FY2021 | $0.02 | +48.8% |
| FY2020 | $0.01 | +513.4% |
| FY2019 | -$0.00 | -163.4% |
| FY2018 | $0.00 | -86.3% |
| FY2017 | $0.04 | +168.7% |
| FY2016 | -$0.05 | +15.3% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026